- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lyell Immunopharma Inc (LYEL)
Assess today's live Lyell Immunopharma Inc (LYEL) share price, performance and insights using our live NASDAQ: LYEL stock exchange data.
Analyse the historical data and Lyell Immunopharma Inc share price performance charts on this page. Our technical summary section provides analysis on Lyell Immunopharma share price buy/sell indicators using real-time data (or discuss the Lyell Immunopharma (LYEL) stock price today with other investors in the Lyell Immunopharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LYEL share price (ISIN: US55083R2031) to enhance your trading decisions with our free investment tools and resources.
What Is the Lyell Immunopharma Inc Share Price Today?
The Lyell Immunopharma share price today is 37.330.
What Is the Stock Symbol for Lyell Immunopharma Inc
The stock symbol (or 'ticker') for Lyell Immunopharma Inc is "LYEL."
What Stock Exchange Does Lyell Immunopharma Inc Trade On?
Lyell Immunopharma Inc is listed and trades on the NASDAQ stock exchange.
Is Lyell Immunopharma Inc a Good Stock to Buy?
Determining whether Lyell Immunopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Lyell Immunopharma Inc share price performance charts on this page. Our technical summary section provides analysis on Lyell Immunopharma share price buy/sell indicators using real-time data (or discuss the Lyell Immunopharma (LYEL) stock price today with other investors in the Lyell Immunopharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LYEL share price (ISIN: US55083R2031) to enhance your trading decisions with our free investment tools and resources.
What Is the Lyell Immunopharma Inc Share Price Today?
The Lyell Immunopharma share price today is 37.330.
What Is the Stock Symbol for Lyell Immunopharma Inc
The stock symbol (or 'ticker') for Lyell Immunopharma Inc is "LYEL."
What Stock Exchange Does Lyell Immunopharma Inc Trade On?
Lyell Immunopharma Inc is listed and trades on the NASDAQ stock exchange.
Is Lyell Immunopharma Inc a Good Stock to Buy?
Determining whether Lyell Immunopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.070
40.690
52 wk Range
7.650
45.000
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.07040.690
52 wk Range
7.65045.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LYEL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
29.667
Downside
-20.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Lyell Immunopharma Inc For: 8 December
- Investing.com
- Century Therapeutics adds two directors to board
- Investing.com
- Century Therapeutics adds two directors to board
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Lyell Immunopharma Company Profile
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company develops therapies using various approaches, such as c-Jun overexpression and NR4A3 gene knockout, to endow functional resistance to exhaustion; Epi-R to generate population of stem-like T cells with reduced exhaustion and improved proliferation and antitumor activity; CD62L positive enrichment to generate CAR T cells with enhanced antitumor activity; and Stim-R, a proprietary synthetic-cell mimetic. It is also developing IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate that is in Phase 1/2 clinical development for the treatment of patients with aggressive relapsed/refractory large B-cell non-Hodgkin lymphoma; and solid tumors program which is in preclinical trial targeting solid tumor indications. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Compare LYEL to Peers and Sector
Metrics to compare | LYEL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLYELPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | −2.5x | −0.6x | |
PEG Ratio | 0.08 | −0.15 | 0.00 | |
Price/Book | 2.4x | 1.4x | 2.6x | |
Price / LTM Sales | 19,318.9x | 193.6x | 3.2x | |
Upside (Analyst Target) | −14.3% | 235.0% | 41.8% | |
Fair Value Upside | Unlock | 13.7% | 5.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 29.667
(-20.53% Downside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-2.13 / -0.1664
Revenue / Forecast
15.00K / --
People Also Watch
FAQ
What Is the Lyell Immunopharma (LYEL) Share Price Today?
The live Lyell Immunopharma share price today is 37.330
What Stock Exchange Does Lyell Immunopharma (LYEL) Trade On?
Lyell Immunopharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Lyell Immunopharma?
The stock symbol (also called a 'ticker') for Lyell Immunopharma is "LYEL."
What Is the Current Lyell Immunopharma Market Cap?
As of today, Lyell Immunopharma market capitalisation is 792.08M.
What Is Lyell Immunopharma's (LYEL) Earnings Per Share (TTM)?
The Lyell Immunopharma EPS is currently -21.06 (Trailing Twelve Months).
Is LYEL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Lyell Immunopharma moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Lyell Immunopharma Stock Split?
Lyell Immunopharma has split 1 times. (See the LYEL stock split history page for full effective split date and price information.)
How Many Employees Does Lyell Immunopharma Have?
Lyell Immunopharma has 300 employees.
What is the current trading status of Lyell Immunopharma (LYEL)?
As of 24 Dec 2025, Lyell Immunopharma (LYEL) is trading at a price of 37.330, with a previous close of 37.370. The stock has fluctuated within a day range of 37.070 to 40.690, while its 52-week range spans from 7.650 to 45.000.
What Is Lyell Immunopharma (LYEL) Price Target According to Analysts?
The average 12-month price target for Lyell Immunopharma is USD29.66667, with a high estimate of USD45 and a low estimate of USD12. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -20.53% Downside potential.
What Is the LYEL Premarket Price?
LYEL's last pre-market stock price is 39.600. The pre-market share volume is 680.000, and the stock has decreased by 2.230, or 5.970%.
What Is the LYEL After Hours Price?
LYEL's last after hours stock price is 36.750, the stock has decreased by -0.580, or -1.550%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.